JANHOFER GUENTER enters QUINCE THERAPEUTICS, INC. with 15.01K shares — 100% direct ownership
Full direct ownership at entry is the strongest form of insider alignment with shareholders.
Direct
Filed: 10/24/2023ACC: 0001209191-23-053505
Officer· Chief Scientific Officer
Since Oct 2023
15.01K
Baseline shares
100% direct
15.01K
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned15.01K
Total
15.01K direct15.01K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 15.01K | Direct |
| Total | 15.01K | 15.01K direct |
Derivative Holdings0
No derivative holdings reported